Quote this publication Share Print

HYCAMTIN

-
Opinions on drugs - Posted on Feb 15 2010

Reason for request

Inclusion on the list of medicines approved for hospital in the new indication: “topotecan in combination with cisplatin is indicated for patients with carcinoma of the cervix recurrent after radiotherapy and for patients with Stage IV-B disease”.

-


Actual benefit

Important

The actual benefit of HYCAMTIN is substantial.


Improvement in actual benefit

IV (mineur)

HYCAMTIN combined with cisplatin only provides a minor improvement in actual benefit (IAB IV) in terms of efficacy compared to cisplatin in treatment of carcinoma of the cervix recurrent after radiotherapy and for patients with Stage IV-B disease.


Contact Us

Évaluation des médicaments
All our publication